Abbvie (ABBV) PT Raised to $181 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $250.33 --0%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Join SI Premium – FREE
Morgan Stanley analyst Terrance Flynn raised the price target on Abbvie (NYSE: ABBV) to $181.00 (from $178.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- Imdex Limited (IMD:AU) (IMDXF) PT Lowered to AUD5.05 at UBS
- Victoria Secret (VSXY) PT Raised to $95 at UBS on Strong Sales, Healthy Margins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
